RNA sequencing applications: What RNA-seq reveals that other methods cannot
RNA sequencing (RNA-seq) has moved from specialized tool to standard method in molecular biology, clinical research, and drug development. Its power lies not just in what it measures, but in what it makes possible: discovering the unexpected, profiling the entire transcriptome in a single experiment, and revealing gene regulation that targeted methods simply cannot see.3
What is RNA sequencing?
RNA sequencing (RNA-seq) is a powerful technique used to analyze the transcriptome, which refers to the complete set of RNA molecules present in a cell, tissue, or organism. RNA-seq enables the comprehensive study of gene expression and provides insights into the transcriptional activity, alternative splicing, RNA processing, and abundance of RNA molecules.
Expression analysis, in the context of RNA-seq, refers to the quantitative measurement and comparison of gene expression levels between different samples or conditions. It involves the identification and quantification of RNA molecules, providing information on which genes are actively transcribed and at what levels.
Overview of the RNA-seq protocol for expression analysis:
Sample Preparation The RNA molecules of interest are extracted from the biological sample (e.g., cells, tissues) and purified to obtain high-quality RNA. Various techniques are used to ensure the preservation of RNA integrity and to remove any contaminating DNA or degraded RNA.
Library Preparation The purified RNA is converted into a sequencing library through a series of steps. These steps typically include RNA fragmentation, reverse transcription to convert RNA into complementary DNA (cDNA), adapter ligation, and PCR amplification. Different library preparation methods and protocols are available, depending on the specific RNA-seq approach and experimental goals.
Sequencing The prepared library is then subjected to high-throughput sequencing using platforms such as Illumina or nanopore sequencing. The sequencing process generates millions to billions of short reads or long reads, depending on the sequencing platform and strategy used. OHMX.bio runs three platforms: Illumina, Element Biosciences AVITI, and Oxford Nanopore, allowing selection of the optimal platform for each research question.
Read Mapping and Alignment The generated sequencing reads are mapped or aligned to a reference genome or transcriptome using bioinformatics tools. This step assigns the reads to specific genomic or transcriptomic locations, allowing the identification of the genes from which the RNA molecules originated.
Quantification The aligned reads are quantified to determine the expression levels of genes or transcripts. Various methods, such as counting the number of reads that align to specific genomic features (e.g., exons, transcripts), are used to quantify gene expression.
Differential Expression Analysis This technique involves comparing gene expression levels between different samples or conditions to identify genes that show significant changes. Statistical methods, embedded in tools like DESeq2, edgeR or LIMMA, are commonly used to identify differentially expressed genes.
Functional Analysis The differentially expressed genes are further analyzed to gain insights into their functional roles, biological pathways, and potential associations with specific phenotypes or conditions. This can involve enrichment analysis, pathway analysis, and integration with other biological databases or annotation resources.
RNA sequencing and expression analysis have revolutionized the study of gene expression and transcriptomic profiling, allowing researchers to gain a comprehensive understanding of gene regulation and molecular processes in various biological systems. It has applications in diverse fields, including developmental biology, cancer research, neuroscience, and precision medicine.
RNA-seq (RNA sequencing) offers several advantages over traditional methods for studying gene expression and transcriptomic profiling. Here are some key reasons why researchers make use of RNA-seq:
Comprehensive Transcriptome Coverage RNA-seq provides a comprehensive view of the transcriptome, allowing researchers to study not only protein-coding genes but also non-coding RNAs, alternative splicing events, and RNA processing. It captures the entire range of RNA molecules present in a sample, providing insights into the complexity and diversity of gene expression.
Quantitative Measurement of Gene Expression RNA-seq enables the quantitative measurement of gene expression levels. It provides information on the abundance and relative expression of genes, allowing researchers to compare expression levels across samples or conditions. This quantitative nature of RNA-seq facilitates the identification of differentially expressed genes and the characterization of gene regulatory networks.
Detection of Novel Transcripts and Splice Variants RNA-seq can identify novel transcripts and alternative splicing events that may be missed by traditional methods. It allows for the discovery of previously unknown isoforms and transcript variants, providing a more comprehensive understanding of gene structure and regulation.
High Sensitivity and Dynamic Range RNA-seq has a wide dynamic range, enabling the detection of both highly expressed and lowly expressed genes. It is sensitive enough to detect rare transcripts and low-abundance RNA molecules that may have important functional roles but are challenging to detect using other techniques.
Genome-Wide Profiling RNA-seq can simultaneously profile the expression of thousands of genes across the entire genome. This genome-wide approach allows for unbiased and comprehensive analysis of gene expression patterns, uncovering global transcriptional changes and providing a holistic view of cellular processes.
Single-Cell Transcriptomics RNA-seq has facilitated the development of single-cell transcriptomics, which enables the study of gene expression at the individual cell level. By sequencing RNA from single cells, researchers can explore cellular heterogeneity, identify rare cell populations, and uncover gene expression dynamics within complex tissues or systems.
Flexibility and Application Versatility RNA-seq can be applied to various biological systems, including model organisms, human samples, and non-model organisms. It is adaptable to different experimental designs and applications, such as time-course studies, disease comparisons, drug response profiling, and biomarker discovery.
Overall, RNA sequencing provides a powerful and versatile tool for studying gene expression and transcriptomic profiling. It enables researchers to gain a deeper understanding of gene regulation, cellular processes, and disease mechanisms, leading to advancements in fields such as genomics, molecular biology, biomedicine, and personalized medicine.
qPCR has long been considered the golden standard to measuring gene expression. qPCR is cheap, relatively fast, scalable and highly sensitive. However, qPCR only makes sense when 1) you already know your exact target and 2) you are only interested in a limited number of targets. As for each target, a primer pair should be available or developed, qPCR is often limited to more common targets. Conversely, RNA-seq is a broad approach which measures the whole, without the need for specific primers or targets. And while the cost of RNA-seq will always be more expensive that running a single qPCR experiment, the balance can quickly shift towards RNA-seq when multiple targets are of interest. RNA-seq is typically the right choice when:
You need discovery, not just confirmation. RNA-seq identifies differentially expressed genes you did not know to look for
You want isoform and splice variant resolution, which standard qPCR cannot provide
You need to detect non-coding RNAs, fusion transcripts, or novel transcripts
Your sample is limited. RNA-seq generates data on thousands of genes from a single experiment
The most robust workflow is to use RNA-seq for discovery and qPCR for targeted validation of selected hits. The two methods are complementary, not competing.4
The origin of RNA sequencing
As a technique, RNA sequencing has been developed and refined by several researchers over time, and it is difficult to attribute its invention to a single individual. However, the concept of using sequencing technologies to study RNA dates back to the early 1990s.
One of the foundational papers that laid the groundwork for RNA-Seq was published in 1994 by researchers Michael Wigler and Robert A. Martienssen. They described a method called “Serial Analysis of Gene Expression” (SAGE), which involved sequencing short tags derived from mRNA transcripts to quantify gene expression levels.
Subsequently, with advancements in high-throughput sequencing technologies and bioinformatics tools, RNA-Seq as we know it today evolved. In the mid-2000s, a team of researchers led by Morten L. Andersen and Christopher T. Harvald at the University of Copenhagen further developed and popularized RNA-Seq for transcriptome analysis. They demonstrated its utility in quantifying gene expression and identifying novel transcripts.
Since then, numerous researchers and laboratories have contributed to the refinement and application of RNA-Seq techniques, leading to its widespread adoption and advancements in the field of genomics.
It’s important to note that the development of RNA-Seq is a collaborative effort within the scientific community, with contributions from multiple researchers and institutions over time.
RNA sequencing applications
RNA sequencing has a wide range of applications across various fields of research and medicine. Here are some key applications based on RNA-seq:
Gene Expression Analysis RNA-seq allows for the quantification and comparison of gene expression levels across different samples or conditions. It provides insights into the genes that are active and their expression levels, facilitating the study of gene regulatory networks, cellular processes, and developmental biology.
Differential Expression Analysis RNA-seq enables the identification of differentially expressed genes between different biological states or disease conditions. This analysis helps uncover genes that are significantly upregulated or downregulated, providing insights into disease mechanisms, biomarker discovery, and potential therapeutic targets.
Alternative Splicing and Transcript Diversity RNA-seq can identify and quantify alternative splicing events and transcript isoforms. It helps uncover the complexity of gene structures and regulatory mechanisms that generate different isoforms. Understanding alternative splicing is important for studying gene function, protein diversity, and disease-related variations.
Non-Coding RNA Analysis RNA-seq enables the profiling of non-coding RNAs, such as micro-, long non-coding and circular RNAs. It allows the identification and quantification of these regulatory RNA molecules, providing insights into their roles in gene regulation, development, and disease.
Transcriptome Assembly and Annotation RNA-seq data can be used to assemble and annotate transcriptomes, particularly in non-model organisms or with incomplete reference genomes. It aids in the discovery of novel transcripts, non-coding RNAs, and gene structures, enhancing the understanding of gene catalogs and genome annotations.
Single-Cell Transcriptomics RNA-seq has revolutionized single-cell transcriptomics, enabling the study of gene expression at the individual cell level. It helps uncover cellular heterogeneity, identify rare cell populations, and explore gene expression dynamics within complex tissues or systems. Single-cell RNA-seq has applications in developmental biology, cancer research, neurobiology, and regenerative medicine.
Pathway and Functional Analysis RNA-seq data can be analyzed to identify enriched biological pathways, functional categories, and molecular processes. This analysis provides insights into the functional implications of gene expression changes and helps understand the underlying biological mechanisms.
Disease Research and Biomarker Discovery RNA-seq enables the identification of transcriptomic signatures associated with diseases, aiding in disease classification, prognosis, and therapeutic target identification. It facilitates the discovery of disease-specific biomarkers, contributing to precision medicine and personalized treatment strategies.
Pharmacogenomics RNA-seq can be used to study the response of cells or tissues to drug treatments. It helps identify genes or pathways that are differentially regulated upon drug exposure, providing insights into drug efficacy, toxicity, and mechanisms of action.
It is considered a reliable and robust technique for studying gene expression and transcriptome analysis. However, like any experimental method, it has its limitations and considerations that need to be taken into account. Here are some factors to consider regarding the reliability of RNA-Seq:
Sensitivity and Accuracy RNA-Seq is highly sensitive and can accurately measure gene expression levels. However, it is influenced by various factors such as library preparation, sequencing depth, and bioinformatics analysis pipelines. Careful experimental design, sample preparation, and data analysis are crucial for obtaining reliable results.
Reproducibility RNA-Seq experiments can generally achieve high levels of reproducibility, especially when standardized protocols and best practices are followed. Replicates and appropriate statistical analyses should be employed to ensure reliable comparisons between samples.
Technical Variability Like any experimental technique, RNA-Seq can have technical variability, which may arise from biases in library preparation, sequencing platforms, or batch effects. Careful consideration and normalization methods can help mitigate such technical variability and improve the reliability of the results.
Reference Annotations and Genome Coverage The reliability of RNA-Seq results heavily depends on the quality and completeness of reference genome annotations. In cases where the reference genome is incomplete or annotations are inaccurate, some genes or transcripts may be missed or misattributed.
Validation It is recommended to validate RNA-Seq results using independent experimental approaches, such as quantitative real-time PCR (qPCR), western blotting, or functional assays, especially for important findings or when studying novel transcripts.
Computational Analysis Proper bioinformatics analysis is critical for extracting reliable information from RNA-Seq data. Choosing appropriate algorithms, quality control measures, and statistical methods is important to minimize false positives or false negatives.
Data Interpretation Interpreting RNA-Seq data requires careful consideration of biological context, potential confounding factors, and functional annotations. It is essential to combine RNA-Seq data with other complementary data sources, such as existing knowledge from literature or functional databases, to gain a comprehensive understanding.
In summary, while RNA-Seq is generally considered reliable, it is crucial to follow best practices, validate findings, and exercise caution during data analysis and interpretation. Rigorous experimental design, appropriate statistical analysis, and quality control measures help ensure the reliability and robustness of RNA-Seq results.
RNA sequencing based on next-generation Illumina or third-generation Nanopore sequencing
RNA-seq can be performed using both next-generation sequencing (NGS) and third-generation sequencing (TGS) technologies. Let’s explore how RNA-seq is implemented in these sequencing platforms:
NGS-Based RNA-seq NGS platforms, such as Illumina sequencing, have been widely used for RNA-seq. The general workflow for NGS-based RNA-seq involves the following steps:
Library Preparation
The RNA sample is converted into a sequencing library through various steps. This includes RNA fragmentation, reverse transcription to convert RNA into complementary DNA (cDNA), adapter ligation, and PCR amplification.
Sequencing
The prepared library is sequenced on an NGS platform, such as Illumina sequencers. These platforms generate short reads, typically ranging from 50 to a few hundred base pairs in length, depending on the specific sequencing chemistry and instrument used.
Data Analysis
The long reads generated by TGS platforms are analyzed using bioinformatics tools to align the reads, quantify gene expression levels, identify alternative splicing events, and perform other transcriptomic analyses.
NGS-based RNA-seq offers high-throughput and high-coverage sequencing, making it suitable for studying gene expression, transcriptome profiling, and related applications. It provides quantitative information and allows for the detection of alternative splicing events and novel transcripts.
TGS-Based RNA-seq Third-generation sequencing platforms, such as nanopore sequencing from Oxford Nanopore Technologies, have also been utilized for RNA-seq. TGS-based RNA-seq offers the advantage of generating long reads, which can capture full-length transcripts and provide information on isoform complexity and alternative splicing. The workflow for TGS-based RNA-seq generally involves the following steps:
Library Preparation The RNA sample is converted into a sequencing library through methods specific to the TGS platform being used. These methods typically involve reverse transcription, adapter ligation, and PCR amplification. Importantly, direct RNA-seq is also available avoiding the PCR amplification step.
Sequencing The prepared library is sequenced using TGS platforms, such as nanopore sequencing. Nanopore sequencing provides long-read capabilities, with reads spanning several kilobases in length.
Data Analysis The long reads generated by TGS platforms are analyzed using bioinformatics tools to align the reads, quantify gene expression levels, identify alternative splicing events, and perform other transcriptomic analyses.
TGS-based RNA-seq is advantageous for capturing long-range information, detecting complex splicing events, studying isoform diversity, and detect RNA modifications. It enables the characterization of full-length transcripts and provides insights into transcriptional regulation and transcriptomic complexity. OHMX.bio is a certified Oxford Nanopore service provider, making it one of the first CROs in Europe to validate this technology for client projects.
Both NGS-based RNA-seq and TGS-based RNA-seq have their strengths and considerations. Researchers choose the appropriate technology based on the specific research goals, sample characteristics, desired read length, throughput, and other factors.
Example 1: Breast Cancer Subtyping and Treatment Response
A study by the Cancer Genome Atlas Network utilized RNA-seq (whole-exome sequencing on 507 patients) to classify breast cancer into distinct molecular subtypes, each with unique gene expression profiles. This classification has significant clinical implications, as it helps in predicting patient prognosis and tailoring treatment strategies. For instance, the study identified a subtype characterized by high expression of immune-related genes, suggesting that these patients might benefit from immunotherapy. RNA-seq’s ability to provide comprehensive and precise gene expression data was crucial in uncovering these clinically relevant subtypes.
Reference: The Cancer Genome Atlas Network. (2012). Comprehensive molecular portraits of human breast tumours. Nature, 490(7418), 61-70.
Example 2: Detecting Fusion Transcripts in Pediatric Leukemia
In pediatric acute lymphoblastic leukemia (ALL), RNA-seq has been instrumental in identifying fusion transcripts that are often missed by traditional methods. A study conducted by Roberts et al. (2014) employed RNA-seq to detect previously unrecognized gene fusions in ALL patients. In total, 136 patients had their transcriptome sequenced. These fusions have significant prognostic and therapeutic implications, as they can serve as biomarkers for disease classification and targets for specific therapies. The study demonstrated that RNA-seq could uncover novel fusion events with high sensitivity and specificity, highlighting its utility in clinical diagnostics and personalized treatment planning.
Reference: Roberts, K. G., et al. (2014). Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. New England Journal of Medicine, 371(11), 1005-1015.
RNA sequencing services offered by OHMX.bio
At OHMX.bio, we are proud to offer high-quality RNA sequencing services using multiple platforms, including Illumina short-read sequencing and Nanopore long-read sequencing.
Our services are tailored to meet your specific research needs, with a personalized project approach. We leverage emerging multi-omics technologies and combine the expertise of our wet lab and high-standard bioinformatics dry lab to deliver exceptional results. Quality is our top priority, and we ensure that every step of the process meets rigorous standards.
Whether you are studying gene expression, transcriptome diversity, alternative splicing, or any other RNA-related research, our experienced team is ready to assist you. We provide comprehensive support, from experimental design and library preparation to data analysis and interpretation.
If you have any questions about our RNA sequencing services or if you are interested in collaborating on a project, we would be delighted to hear from you. Please feel free to reach out, and our team will be more than happy to assist you. Contact us today to embark on your RNA sequencing journey!
RNA-seq has no upper detection limit and covers the full transcriptome without predefined probes, detecting novel transcripts, non-coding RNAs, and alternative splicing events that microarrays cannot. It also has a superior dynamic range for detecting both highly and lowly expressed genes.3
Drug mechanism-of-action studies, biomarker discovery, patient stratification, mRNA therapeutic development, companion diagnostic development, and pharmacogenomics studies are the most frequent applications in pharmaceutical research.3
Yes. Formalin-fixed paraffin-embedded (FFPE) RNA is typically degraded, but OHMX.bio has validated optimised protocols for FFPE RNA-seq that deliver reliable results even from archival tissue.3
Nanopore long-read RNA-seq is preferred when isoform resolution, direct RNA modification detection, or full-length transcript sequencing are required. Illumina short-read remains the standard for high-throughput differential expression analysis where read length is not limiting.3
Do you have questions about ribosome profiling?
Fill out the form below and our experts will get back to you as soon as possible!
Do you have questions about RNA sequencing?
Fill out the form below and our experts will get back to you as soon as possible!
[1] The Cancer Genome Atlas Network. (2012). Comprehensive molecular portraits of human breast tumours. Nature, 490(7418), 61–70. https://doi.org/10.1038/nature11412
[2] Roberts, K. G., et al. (2014). Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. New England Journal of Medicine, 371(11), 1005–1015. https://doi.org/10.1056/NEJMoa1403088
[3] Stark, R., Grzelak, M., & Hadfield, J. (2019). RNA sequencing: the teenage years. Nature Reviews Genetics, 20(11), 631–656. https://doi.org/10.1038/s41576-019-0150-2
[4] Zhao, S., Fung-Leung, W. P., Bittner, A., Ngo, K., & Liu, X. (2014). Comparison of RNA-Seq and microarray in transcriptome profiling of activated T cells. PLoS ONE, 9(1), e78644. https://doi.org/10.1371/journal.pone.0078644
Manage Consent
We use cookies to improve your experience on our site and understand how our content is used. This includes essential cookies for site functionality, as well as optional cookies for analytics and marketing. You can accept all cookies, decline non-essential ones, or manage your preferences below. Declining certain cookies may limit some site features.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
